Skip to main content

Starling Oncology, Inc.

STLNW
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0001799191

In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.

Other share classesDFPHSTLN

13F holders, Q1 2022

Institutional positions in Starling Oncology, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
14
−8 vs. Q4 2021
Shares held
3.32M
+576.1K (+21.0%) vs. Q4 2021
Total value
$3.90M
+$1.33M (+52.1%) vs. Q4 2021
New holders
0
2 more added
Sold out
8
2 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting STLNW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 14 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 22 institutionsQ1 2022: 14 institutionsQ2 2022: 13 institutionsQ3 2022: 14 institutionsQ4 2022: 14 institutionsQ1 2023: 17 institutionsQ2 2023: 15 institutionsQ3 2023: 15 institutionsQ4 2023: 16 institutionsQ1 2024: 15 institutionsQ2 2024: 18 institutionsQ3 2024: 15 institutionsQ4 2024: 14 institutionsQ1 2025: 11 institutionsQ2 2025: 11 institutionsQ3 2025: 12 institutionsQ4 2025: 11 institutionsQ1 2026: 11 institutionsQ2 2026: 12 institutions
Value heldQ1 2022: $3.90M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $2.56MQ1 2022: $3.90MQ2 2022: $1.61MQ3 2022: $1.78MQ4 2022: $346.4KQ1 2023: $232.3KQ2 2023: $132.4KQ3 2023: $406.9KQ4 2023: $806.9KQ1 2024: $827.5KQ2 2024: $108.0KQ3 2024: $52.0KQ4 2024: $19.0KQ1 2025: $94.9KQ2 2025: $195.4KQ3 2025: $469.0KQ4 2025: $465.1KQ1 2026: $172.4KQ2 2026: $163.5K
Institutions holding STLNW and their total value by quarter
QuarterHoldersValue
Q2 202612$163.5K
Q1 202611$172.4K
Q4 202511$465.1K
Q3 202512$469.0K
Q2 202511$195.4K
Q1 202511$94.9K
Q4 202414$19.0K
Q3 202415$52.0K
Q2 202418$108.0K
Q1 202415$827.5K
Q4 202316$806.9K
Q3 202315$406.9K
Q2 202315$132.4K
Q1 202317$232.3K
Q4 202214$346.4K
Q3 202214$1.78M
Q2 202213$1.61M
Q1 202214$3.90M
Q4 202122$2.56M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q4 2021.

Institutions holding STLNW in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Deerfield Management Company, L.P. (Series C)1,250,000$1.44M0.03%00.0%Unchanged
Highbridge Capital Management LLC–$1.20M0.03%––
Davidson Kempner Capital Management LP318,710$367.0K0.01%00.0%Unchanged
Jefferies Group LLC155,457$178.8K0.00%−19,543−11.2%Reduced
Difesa Capital Management, LP125,000$144.0K0.09%00.0%Unchanged
Union Square Park Capital Management, LLC120,000$138.0K0.11%00.0%Unchanged
Man Group plc94,740$109.0K0.00%00.0%Unchanged
Wolverine Asset Management LLC91,966$105.0K0.00%−21,320−18.8%Reduced
Healthcare of Ontario Pension Plan Trust Fund87,500$101.0K0.00%00.0%Unchanged
JPMorgan Chase & Co–$58.0K0.00%––
Tenor Capital Management Co., L.P.25,000$29.0K0.00%00.0%Unchanged
Alpine Global Management, LLC25,024$29.0K0.01%00.0%Unchanged
UBS Group AG4,474$5.00K0.00%+102+2.3%Added
LMR Partners LLP1,023,991––+858,573+519.0%Added
Bulldog Investors, LLP0$00.00%−75,267−100.0%Sold out
Park West Asset Management LLC0$00.00%−62,200−100.0%Sold out
Greenhaven Road Investment Management, L.P.0$00.00%−47,003−100.0%Sold out
HBK Investments L P0$00.00%−14,000−100.0%Sold out
CSS LLC0$00.00%−14,136−100.0%Sold out
DuPont Capital Management Corp0$00.00%−12,500−100.0%Sold out
Virtu Financial LLC0$00.00%−12,603−100.0%Sold out
Captrust Financial Advisors0$00.00%−3,957−100.0%Sold out